| Periods | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | All Time |
|---|---|---|---|---|---|---|---|
| Primex-40 | |||||||
| Bateli Tea Company Limited |
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Non-Current Assets |
|
|
|
Property,
Plant and Equipment |
12,794.69 |
11,530.02 |
|
Capital
Work-in-Progress |
2,306.88 |
1,494.76 |
|
Financial
Assets |
|
|
|
Others
Financial Assets |
35.20 |
35.20 |
|
Other
Non-Current Assets |
109.45 |
98.40 |
|
Current Assets |
|
|
|
Inventories |
2,358.41 |
2,381.19 |
|
Biological
Assets other than Bearer Plants |
5.55 |
41.71 |
|
Investments |
1,920.06 |
1,585.33 |
|
Trade
Receivables |
2,463.32 |
1,997.42 |
|
Cash
& Cash Equivalents |
48.16 |
133.85 |
|
Other
Financial Assets |
201.74 |
287.53 |
|
Other Current
Assets |
1,475.70 |
355.28 |
|
Total Assets |
23,719.16 |
19,940.69 |
|
Equity |
|
|
|
Equity
Share Capital |
21.42 |
21.42 |
|
Other
Equity |
12,517.53 |
11,531.24 |
|
Non-Current Liabilities |
|
|
|
Borrowings |
4,998.82 |
2,654.45 |
|
Deferred
Tax Liabilities (Net) |
268.72 |
441.02 |
|
Other Non-Current
Liabilities |
205.72 |
191.54 |
|
Current Liabilities |
|
|
|
Borrowings |
3,565.15 |
3,234.15 |
|
Trade
Payables |
|
|
|
Total
outstanding dues of creditors other than Micro enterprise & small
enterprise |
402.58 |
173.71 |
|
Total
outstanding dues of Micro enterprise & small enterprise |
14.07 |
116.34 |
|
Other
Financial Liabilities |
1,492.68 |
1,317.35 |
|
Other
Current Liabilities |
198.80 |
240.39 |
|
Current
Tax Liabilities (Net) |
33.67 |
19.08 |
|
Total Equity and Liabilities |
23,719.16 |
19,940.69 |
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Income |
|
|
|
Revenue from Operations |
12,120.53 |
8,091
.69 |
|
Other Income |
81.43 |
163.72 |
|
Total Income |
12,201.96 |
8.255.41 |
|
Expenses |
|
|
|
Cost of material consumed |
6,303.47 |
4,014.02 |
|
Purchase
of Stock-in-Trade |
1,040.63 |
- |
|
Changes
in inventories of Finished Goods, Work-In-Progress and Stock-in-Trade |
-94.71 |
-488.48 |
|
Employee Benefit Expenses |
1,459.94 |
1,391.10 |
|
Finance Costs |
652.50 |
509.78 |
|
Depreciation & amortization expense |
603.20 |
570.46 |
|
Other Expenses |
1,286.94 |
1,410.54 |
|
Total Expenses |
11,251.97 |
7,407.42 |
|
Profit/(Loss) Before Tax |
949.99 |
847.99 |
|
Current Tax |
130.83 |
120.51 |
|
Deferred Tax |
-170.86 |
-171.89 |
|
Profit/(Loss) after tax |
990.02 |
899.37 |
|
Other Comprehensive Income |
|
|
|
Items
that will not be reclassified to profit and loss |
-5.17 |
15.92 |
|
Tax
relating to above items |
1.44 |
-4.43 |
|
Total Comprehensive income for the period |
986.29 |
910.86 |
|
Earnings per share |
|
|
|
Basic |
462.19 |
419.87 |
|
Diluted |
462.19 |
419.87 |
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Cash Flow from Operating Activities |
|
|
|
Profit
before taxation as per statement of Profit & Loss |
949.99 |
847.99 |
|
Adjustments for: |
|
|
|
Depreciation
and amortization expense |
603.20 |
570.46 |
|
Finance
Costs |
652.50 |
509.78 |
|
Provision
for gratuity |
29.30 |
28.74 |
|
Other
non-operating income |
-3.35 |
1.93 |
|
Interest
income |
-5.07 |
-11.13 |
|
Changes
in fair value of biological assets (Net) |
36.16 |
-36.37 |
|
Amortisation of government grants – capital
subsidy |
-7.49 |
-7.49 |
|
Net
Gain arising on financial assets mandatorily measured at FVTPL |
0.26 |
-0.45 |
|
Operating profit / (loss) before adjustments for (increase) /decrease in operating assets/liabilities |
2,255.50 |
1,903.46 |
|
Adjustments for (increase)/decrease in operating assets: |
|
|
|
Inventories |
22.78 |
-442.22 |
|
Trade receivables |
-465.90 |
-985.48 |
|
Current
Investments and other financial assets |
-1,467.31 |
-88.30 |
|
Adjustments
for increase / (decrease) in operating liabilities. |
|
|
|
Trade payables |
126.60 |
-69.78 |
|
Other financial liabilities |
120.91 |
44.73 |
|
Cash generated from operations |
592.58 |
362.41 |
|
Net
income tax (paid) / refunds |
-116.27 |
-101.56 |
|
Net cash flow from / (used in) Operating
Activities |
476.31 |
260.85 |
|
Cash flow from investing Activities |
|
|
|
Capital
expenditure on fixed assets, including capital advances |
-2,704.25 |
-2,430.55 |
|
Interest
received |
102.76 |
0.03 |
|
Increase
/ (Decrease) in Long Term & Short Term Financial Assets |
100.45 |
-34.82 |
|
Net cash flow from / (used in) Investing
Activities |
-2,501.04 |
-2,465.34 |
|
Cash flow from Financing Activities |
|
|
|
Increase
/ (Decrease) in long-term borrowings |
2,344.37 |
1,548.89 |
|
Increase
/ (Decrease) in short-Term borrowings |
330.99 |
187.26 |
|
Increase
/ (Decrease) in Long Term/Short Term Loans |
76.40 |
991.50 |
|
Finance
cost |
-812.72 |
-509.78 |
|
Net cash flow from / (used in) Financing
Activities |
1,939.04 |
2,217.87 |
|
Net
increase / (decrease) in Cash and cash equivalents |
-85.69 |
13.38 |
|
Cash
and cash equivalents at the beginning of the year |
133.85 |
120.47 |
|
Cash and cash equivalents at the end of
the year |
48.16 |
133.85 |
Summary
of the Cash Flow Statement for the years 2025 and 2024:
Cash
Flow from Operating Activities
In FY25, Bateli Tea Company Limited
reported higher profit before tax of ₹949.99 lakhs compared to ₹847.99 lakhs in
FY24, reflecting improved accounting performance. Depreciation and finance
costs increased due to higher capital investment and borrowings, while
biological asset valuation showed a loss adjustment compared to last year’s
gain. Consequently, operating profit before working capital changes rose
significantly to ₹2,255.50 lakhs from ₹1,903.46 lakhs.
However, working
capital movements absorbed substantial cash. Although inventories declined
slightly, trade receivables and financial assets increased sharply, leading to
major cash outflows, partially offset by higher trade payables and other
liabilities. As a result, cash generated from operations stood at ₹592.58
lakhs, and after tax payments, net operating cash flow improved to ₹476.31
lakhs (FY24: ₹260.85 lakhs). Overall, while core operations are generating
stronger cash flows, increased funds locked in receivables and investments are
limiting liquidity.
Cash
Flow from Investing Activities
Investing activities
remained significantly negative during FY25, with capital expenditure
increasing to ₹2,704.25 lakhs from ₹2,430.55 lakhs in the previous year,
indicating continued expansion and asset development. Interest income improved
to ₹102.76 lakhs, and changes in financial assets resulted in a small inflow;
however, these were insufficient to offset the large capital outlay.
Consequently, net cash used in investing activities stood at ₹2,501.04 lakhs,
broadly in line with last year’s ₹2,465.34 lakhs. This reflects that the
company is in an investment-intensive phase, and sustained high capital
expenditure will require strong operating cash flows or continued reliance on
debt funding.
Cash
Flow from Financing Activities
During FY25, financing
activities generated strong cash inflows, primarily driven by an increase in
long-term borrowings of ₹2,344.37 lakhs and short-term borrowings of ₹330.99
lakhs, along with additional inflows from loan movements. However, finance
costs paid rose significantly to ₹812.72 lakhs, reflecting the higher debt
burden. As a result, net cash from financing activities stood at ₹1,939.04
lakhs, slightly lower than ₹2,217.87 lakhs in the previous year but still
substantial. This indicates that the company is largely funding its capital
expenditure through debt, and the rising finance costs confirm increasing
leverage, consistent with the higher debt–equity ratio.
Net
Movement in Cash
Despite generating
positive operating cash flows, substantial capital expenditure and significant
deployment of funds into working capital resulted in a net cash outflow of
₹85.69 lakhs in FY25, compared to a net increase of ₹13.38 lakhs in the
previous year. Consequently, the closing cash balance declined sharply to
₹48.16 lakhs from ₹133.85 lakhs. This trend indicates tightening liquidity even
as the company continues its expansion efforts.
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Current ratio |
1.48 |
1.33 |
|
Debt equity ratio |
0.78 |
0.60 |
|
Debt service coverage
ratio |
2.07 |
2.14 |
|
Return on equity ratio |
7.90% |
7.78% |
|
Inventory turnover ratio |
3.72 |
4.20 |
|
Trade receivables turnover ratio |
5.43 |
5.38 |
|
Trade payables turnover ratio |
16.32 |
19.81 |
|
Net capital turnover
ratio |
4.38 |
4.81 |
|
Net profit ratio |
8.17% |
11.11% |
|
Return on capital employed |
6.00% |
6.45% |
|
Return on Investments |
138.95% |
236.84% |
Summary of the financial ratios for the years 2025 and 2024:
Current
Ratio
The current ratio
improved to 1.48
in FY25 from 1.33
in FY24. This indicates better short-term liquidity and an improved ability to
meet current obligations. A ratio above 1 suggests the company has sufficient
current assets to cover short-term liabilities. The improvement reflects
stronger working capital management, though the level remains moderate rather
than highly comfortable.
Debt–Equity
Ratio
The debt–equity
ratio increased to 0.78
from 0.60,
indicating higher reliance on debt financing during FY25. While leverage has
increased, the ratio remains within a reasonable range and does not signal
excessive financial risk. However, the rising trend suggests the company is
moderately increasing its financial gearing, which could increase interest
burden in future periods.
Debt
Service Coverage Ratio
DSCR declined
slightly to 2.07
from 2.14.
Despite the marginal drop, the ratio remains comfortably above 1.5, indicating
strong capacity to service debt obligations from operating earnings. The slight
decline may be due to increased borrowings or slightly lower operating profits.
Return on
Equity
ROE improved
marginally to 7.90%
from 7.78%.
This indicates stable profitability for shareholders. However, the return
remains moderate and suggests limited value creation compared to
higher-yielding opportunities. The improvement, though small, reflects steady
earnings performance.
Inventory
Turnover Ratio
Inventory turnover
declined to 3.72
from 4.20,
indicating slower inventory movement during FY25. This could suggest higher
stock holding, slower sales, or weaker demand conditions. Lower turnover
increases holding costs and may impact margins if inventory aging becomes an
issue.
Trade
Receivables Turnover Ratio
The receivables
turnover improved slightly to 5.43
from 5.38,
indicating marginally better collection efficiency. The company appears
consistent in managing credit sales and maintaining cash flow discipline.
Trade
Payables Turnover Ratio
Payables turnover
declined to 16.32
from 19.81,
meaning the company is taking slightly longer to pay suppliers compared to last
year. This could be a strategic move to improve working capital, but it may
also indicate tighter liquidity management.
Net
Capital Turnover Ratio
Net capital turnover
decreased to 4.38
from 4.81,
suggesting reduced efficiency in utilizing capital to generate revenue. This
aligns with slower inventory turnover and declining profitability margins.
Net
Profit Ratio
Net profit margin
fell significantly to 8.17%
from 11.11%.
This is a key concern. The decline suggests higher operating costs, lower pricing
power, or margin compression. Despite stable revenues, profitability has
weakened.
Return on
Capital Employed
ROCE declined to 6.00% from 6.45%, indicating
slightly reduced efficiency in using overall capital. The return remains modest
and may be below the company’s cost of capital, which can limit long-term value
creation.
Return on
Investments
Return on
investments dropped sharply to 138.95%
from 236.84%.
Although still high, the significant decline suggests lower non-operating
income or reduced gains on investments compared to the previous year.